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Programmed ventricular stimulation (PVS) after myocardial infarction
(MI) was used 20 years ago to stratify arrhythmic risks. Recent studies
recommend PVS early after MI to detect a risk of ventricular tachycardia
(VT) and sudden death (SD). The purpose of the study was to look for the
actual prognostic significance of inducible ventricular arrhythmias after
MI.
Methods: PVS was performed between 1985 and January 2012, from 4 to
8 weeks after acute MI in 808 patients with MI, without syncope or ventric-
ular arrhythmias. LVEF was evaluated by echocardiography. PVS used the
same protocol (up to 3 extrastimuli in 2 sites of right ventricle).
Results: Monomorphic VT <270 bpm was induced in 184 patients (23%),
ventricular flutter (VT>265 bpm) or fibrillation (VF) in 206 (25%). PVS
remained negative in 418 patients (52%). Mean follow-up was 8±6.5 years.
Cardiac defibrillator (ICD) was implanted in 83 patients from 1994 (10%).
Nineteen patients developed spontaneous sustained VT, 35 died suddenly;
103 died from heart failure or were transplanted (HF); 11 died from a non-
cardiac cause. Their comparison with patients alive or dying from noncardiac
death (n=660) indicated that monomorphic VT induction was the only univar-
iate predictor of SD (37%)(p<0.01) or HF-related death (39%) (p<0.00009).
Low LVEF was only significant in patients who died suddenly (36±13%)
compared to alive patients (43±13) (p<0.01). Age, gender did not differ. VF
induction (26% of alive patients) was not significantly associated with SD
(31%) or HF-related death (23%). The implantation of ICD has probably
changed the cause of cardiac death with increasing death from HF: 24% of
patients who died from HF received ICD compared to 7% of alive patients
(p<0.0000); 1 patient with ICD died suddenly (1%)(NS compared with total
group (4%).
Conclusions: Induction of a monomorphic VT remains an important pre-
dictor of cardiac mortality. Induction of ventricular flutter or fibrillation did
not increase cardiac mortality. Through the years the heart failure-related
deaths tended to increase and SD to decrease because of ICD implantation in
patients with inducible VT or low LVEF.
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Introduction: Little is known regarding the role of LVEF in ventricular
arrhythmia recurrence. The aim of this study was to assess the correlation
between LVEF and ventricular arrhythmia recurrence in patients with isch-
emic (ICM) or non ischemic (NICM) cardiomyopathies implanted with an
Implantable Cardiac Defibrillator (ICD) for secondary prevention.
Methods: Data on all consecutive patients implanted with an ICD were
retrieved from the database of our institution. Among 1334 patients implanted
with an ICD, 554 had their device for secondary prevention and 307 had a his-
tory of ICM or NICM. The total ICD therapies (shocks and ATP), ATP only
and shocks only were collected. We compared the proportion of patients
receiving ICD therapies in 2 groups: group 1 (patients with a LVEF >35%)
and group 2 (patients with a LVEF<= 35%).
Results: Among 307 patients (mean age 64 +/-10, 29 women),
157 received ICD therapies. The proportion of patients receiving total ICD
therapies was higher in group 1 than in group 2 (72.1 vs. 57.1% p< 0.01).
There was no difference regarding the proportion of patients receiving
total appropriate ICD therapies, appropriate ATP therapies and appropriate
shocks, between group 1 and group 2 (60.3 vs. 52.9% p=NS; 38.2 vs. 37.6
p=NS; 22.1 vs 15.3% p=NS; respectively). The proportion of patients
receiving inappropriate total ICD therapies was higher in group 1 than in
group 2 (11.8 vs. 4.2% p< 0.05). The proportion of patients receiving inap-
propriate ATP therapies was higher in group 1 than in group 2 (8.8 vs.
3.1% p< 0.05). There was no difference regarding the proportion of
patients receiving inappropriate shocks between group 1 and group 2 (2.9
vs. 2.1% p=NS).
Conclusion: LVEF is not correlated with ventricular arrhythmia recurrence
in patients with DCM or ICM implanted with an ICD for secondary preven-
tion. However, the proportion of patients receiving inappropriate ICD thera-
pies was higher in patient with a LVEF>35% than in patients with a
LVEF<=35%.
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Introduction: Frequent premature ventricular beats (PVB) may induce car-
diomyopathy (CM) whose characteristics and underlying mechanisms are
poorly known
Methods: 38 patients (27 men, 57±16yo) with dilated CM associated with
frequent isolated PVB suspected to be responsible the CM were ablated
between 2005 and 2011. PVB were documented <1 year (n=11), between 1
and 5 years (n=8) and >5 years (n=10) before (unknown in 9). Ejection frac-
tion (EF), left ventricular end-diastolic diameter (LVEDD) and NYHA class
were compared before and after radio-frequency ablation. 16 pts with symp-
tomatic PVB without CM serves as the control group
Results: Baseline EF was 39±1%, LVEDD was 61±7 mm and mean
NYHA class was 1.9±0.8. PVB arose from the RV in 10 pts (RVOT in 7) and
from the LV in 28 pts (LVOTt in 10 and coronary cusps in 10)
Compared to the control group, daily PVB number was not different in pts
with suspected VPB-induced CM (22000±12000 vs 20000±14000, p=ns), as
was the presence of PVB left bundle branch pattern (24/38 vs 13/16, p=ns)
and gender or age. Pts with suspected PVB-induced CM had more often right
axis VPB (31/37 vs 10/16, p=0.08). History of PVB was shorter in controls.
Origin of the PVB did not differ between groups
RF ablation completely eliminated PVB in 26 pts (68%), partially in 4 and
was inefficient in 8. During a follow up of 19±19 months, EF increased from
39±10 to 52±13% (p=0.003) while LVEDD decrease from 61±7 to 56±7 mm
(p=0.002) leading to a decrease in NYHA class (1.9±0.8 to 1.4±0.6,p=0.02).
Parameters related to the failure of ablation were an older age, a higher
NYHA class and a LVOT location of the focus. Parameters related to the lack
of reversal of CM in successful ablations, were an older age, a lower baseline
EF, but not the length of PVB history.
Conclusion: RF ablation of frequent PVB may lead to cure or signifi-
cant improvement in 78% of pts with associated CM. Plausible mecha-
nisms leading to a PVB-induced CM may associate a more longer history
of PVB.
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